PNC FINANCIAL SERVICES GROUP, INC. - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$88,000
+23.9%
584
+21.7%
0.00%
Q2 2022$71,000
-19.3%
480
-34.7%
0.00%
Q1 2022$88,000
-33.8%
735
-24.0%
0.00%
Q4 2021$133,000
+18.8%
967
+19.7%
0.00%
Q3 2021$112,000
+57.7%
808
+9.8%
0.00%
Q2 2021$71,000
+24.6%
736
-12.9%
0.00%
Q1 2021$57,000
-60.4%
845
-49.6%
0.00%
Q4 2020$144,000
+26.3%
1,676
-3.7%
0.00%
Q3 2020$114,000
-8.1%
1,741
+1.5%
0.00%
Q2 2020$124,000
+12300.0%
1,715
+6251.9%
0.00%
Q1 2020$1,000
-75.0%
27
-68.6%
0.00%
Q3 2019$4,000
-20.0%
86
-13.1%
0.00%
Q2 2019$5,00099
+280.8%
0.00%
Q1 2018$0260.0%0.00%
Q4 2017$0
-100.0%
26
+8.3%
0.00%
Q3 2017$1,0000.0%24
-40.0%
0.00%
Q2 2017$1,000400.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2022
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$154,344,00072.03%
Knoll Capital Management, LLC 856,844$119,024,00059.36%
ORACLE INVESTMENT MANAGEMENT INC 2,124,055$295,053,00036.73%
ARS Investment Partners, LLC 466,668$64,825,0006.49%
KINGDON CAPITAL MANAGEMENT, L.L.C. 365,373$50,754,0006.18%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$24,490,0005.91%
SILVERARC CAPITAL MANAGEMENT, LLC 61,897$8,598,0004.86%
DAFNA Capital Management LLC 88,100$12,238,0003.25%
Avidity Partners Management LP 934,200$129,770,0002.88%
Eventide Asset Management 1,325,000$184,056,0002.43%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders